Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Март 29, 2024
Abstract
Chromosomal
instability
(CIN)
is
a
hallmark
of
cancer
and
associated
with
tumor
cell
malignancy.
CIN
triggers
chain
reaction
in
cells
leading
to
chromosomal
abnormalities,
including
deviations
from
the
normal
chromosome
number
or
structural
changes
chromosomes.
arises
errors
DNA
replication
segregation
during
division,
formation
abnormal
and/or
structure
Errors
result
licensing
as
well
stress,
such
double-strand
breaks
stalled
forks;
meanwhile,
stem
defects
machinery,
centrosome
amplification,
erroneous
microtubule–kinetochore
attachments,
spindle
assembly
checkpoint,
defective
sister
chromatids
cohesion.
In
cells,
deleterious
damage,
proteotoxic
metabolic
alteration,
cycle
arrest,
senescence.
Paradoxically,
despite
these
negative
consequences,
one
hallmarks
found
over
90%
solid
tumors
blood
cancers.
Furthermore,
could
endow
enhanced
adaptation
capabilities
due
increased
intratumor
heterogeneity,
thereby
facilitating
adaptive
resistance
therapies;
however,
excessive
induce
death,
“just-right”
model
for
tumors.
Elucidating
complex
nature
crucial
understanding
dynamics
tumorigenesis
developing
effective
anti-tumor
treatments.
This
review
provides
an
overview
causes
consequences
CIN,
paradox
phenomenon
that
continues
perplex
researchers.
Finally,
this
explores
potential
CIN-based
therapy.
Cell
death
is
a
fundamental
part
of
life
for
metazoans.
To
maintain
the
balance
between
cell
proliferation
and
metabolism
human
bodies,
certain
number
cells
need
to
be
removed
regularly.
Hence,
mechanisms
have
been
preserved
during
evolution
multicellular
organisms.
Tumorigenesis
closely
related
with
exceptional
inhibition
death.
Mutations
or
defects
in
death-related
genes
block
elimination
abnormal
enhance
resistance
malignant
chemotherapy.
Therefore,
investigation
enables
development
drugs
that
directly
induce
tumor
In
guidelines
updated
by
Death
Nomenclature
Committee
(NCCD)
2018,
was
classified
into
12
types
according
morphological,
biochemical
functional
classification,
including
intrinsic
apoptosis,
extrinsic
mitochondrial
permeability
transition
(MPT)-driven
necrosis,
necroptosis,
ferroptosis,
pyroptosis,
PARP-1
parthanatos,
entotic
death,
NETotic
lysosome-dependent
autophagy-dependent
immunogenic
cellular
senescence
mitotic
catastrophe.
The
mechanistic
relationships
epigenetic
controls
cancer
progression
were
previously
unclear.
this
review,
we
will
summarize
pathways
corresponding
regulations.
Also,
explore
extensive
interactions
these
discuss
epigenetics
which
bring
benefits
therapy.
Computational and Structural Biotechnology Journal,
Год журнала:
2025,
Номер
27, С. 321 - 332
Опубликована: Янв. 1, 2025
Mitotic
checkpoints
orchestrate
cell
division
through
intricate
molecular
networks
that
ensure
genomic
stability.
While
experimental
research
has
uncovered
key
aspects
of
checkpoint
function,
the
complexity
protein
interactions
and
spatial
dynamics
necessitates
computational
modeling
for
a
deeper,
system-level
understanding.
This
review
explores
mathematical
frameworks-from
ordinary
differential
equations
to
stochastic
simulations,
which
reveal
across
multiple
scales,
encompassing
models
ranging
from
simple
whole-system
simulations
with
thousands
parameters.
These
approaches
have
elucidated
fundamental
properties,
including
bistable
switches
driving
spindle
assembly
(SAC)
activation,
organization
principles
underlying
position
(SPOC)
signaling,
critical
features
ensuring
robustness.
study
evaluates
diverse
approaches,
rule-based
chemical
theory,
highlighting
their
successful
application
in
predicting
localization
patterns
response
validated
live-cell
imaging.
Contemporary
challenges
persist
integrating
temporal
refining
parameter
estimation,
enhancing
fidelity.
However,
recent
advances
single-molecule
imaging,
data-driven
algorithms,
machine
learning
techniques,
particularly
deep
optimization,
present
transformative
opportunities
improving
model
accuracy
predictive
power.
By
bridging
mechanisms
behaviors
frameworks,
this
offers
comprehensive
perspective
on
cycle
control,
practical
implications
cancer
therapeutic
development.
IntechOpen eBooks,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 6, 2025
This
chapter
explores
how
to
regulate
programmed
cell
death
and
its
relevance
in
cancer
therapy.
It
points
the
need
of
investigate
mechanisms
death,
like
apoptosis,
necroptosis,
and,
more
recently,
exposed
ferroptosis,
while
creating
approaches
for
treatment
malignant
diseases.
In
spite
progress
field
targeted
therapies,
is
still
a
main
cause
due
incapability
cells
undergo
apoptosis.
The
highlights
significance
adopting
complex
that
encompass
multiple
types
occurring
within
both
tumor
microenvironment.
Of
note
are
functions
oncogenes
suppressor
genes
regulation
cellular
processes,
specific
role
apoptosis
formation
process,
possibility
increase
neoplastic
cells.
There
metastasis
critical
such
as
TP53
gene,
along
with
presence
an
over
expression
anti-apoptotic
proteins.
Examples
this
would
include
Bcl-2
IAPs,
which
protect
against
stimuli
required
death.
immunotherapy
combination
therapies
described
emerging
strategies
enhance
efficacy
treatments.
document
also
deals
problem
resistance
induction
necessity
further
clinical
studies
new
therapeutic
agents
practice.
summary,
it
diversity
biology
paradigm
shift
achieve
Cell Death Discovery,
Год журнала:
2024,
Номер
10(1)
Опубликована: Авг. 29, 2024
The
balance
of
programmed
cell
death
(PCD)
mechanisms,
including
apoptosis,
autophagy,
necroptosis
and
others,
is
pivotal
in
cancer
progression
treatment.
Dysregulation
these
pathways
results
uncontrolled
growth
resistance
to
conventional
therapies.
Nanomedicine
offers
a
promising
solution
oncology
through
targeted
drug
delivery
enabling
precise
targeting
cells
while
preserving
healthy
tissues.
This
approach
reduces
the
side
effects
traditional
chemotherapy
enhances
treatment
efficacy
by
engaging
PCD
pathways.
We
details
each
pathway,
their
innovative
nanomedicine
strategies
activate
pathways,
thereby
enhancing
therapeutic
specificity
minimizing
harm
precision
nanotechnology
promises
significant
improvements
outcomes.
synergy
between
activation
could
lead
more
effective
less
toxic
therapies,
heralding
new
era